These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. BvrR/BvrS-controlled outer membrane proteins Omp3a and Omp3b are not essential for Brucella abortus virulence. Manterola L; Guzmán-Verri C; Chaves-Olarte E; Barquero-Calvo E; de Miguel MJ; Moriyón I; Grilló MJ; López-Goñi I; Moreno E Infect Immun; 2007 Oct; 75(10):4867-74. PubMed ID: 17664262 [TBL] [Abstract][Full Text] [Related]
25. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model. Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473 [TBL] [Abstract][Full Text] [Related]
26. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242 [TBL] [Abstract][Full Text] [Related]
27. Gateway-based destination vectors for functional analyses of bacterial ORFeomes: application to the Min system in Brucella abortus. Hallez R; Letesson JJ; Vandenhaute J; De Bolle X Appl Environ Microbiol; 2007 Feb; 73(4):1375-9. PubMed ID: 17172460 [TBL] [Abstract][Full Text] [Related]
28. A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice. Delpino MV; Marchesini MI; Estein SM; Comerci DJ; Cassataro J; Fossati CA; Baldi PC Infect Immun; 2007 Jan; 75(1):299-305. PubMed ID: 17088355 [TBL] [Abstract][Full Text] [Related]
29. Outcome and immune responses after Brucella abortus infection in young adult and aged mice. High KP; Prasad R; Marion CR; Schurig GG; Boyle SM; Sriranganathan N Biogerontology; 2007 Oct; 8(5):583-93. PubMed ID: 17653832 [TBL] [Abstract][Full Text] [Related]
30. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection. Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251 [TBL] [Abstract][Full Text] [Related]
31. [Molecular characterization of Brucella abortus strain 19 and its application for controlling biologics]. Pavan ME; Nicola A; Grimoldi F; Cairó F Rev Argent Microbiol; 2005; 37(3):122-5. PubMed ID: 16323658 [TBL] [Abstract][Full Text] [Related]
32. ER-mediated phagocytosis: a new membrane for new functions. Desjardins M Nat Rev Immunol; 2003 Apr; 3(4):280-91. PubMed ID: 12669019 [TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Connolly JP; Comerci D; Alefantis TG; Walz A; Quan M; Chafin R; Grewal P; Mujer CV; Ugalde RA; DelVecchio VG Proteomics; 2006 Jul; 6(13):3767-80. PubMed ID: 16739129 [TBL] [Abstract][Full Text] [Related]
34. Risk of infection with Brucella abortus and Escherichia coli O157:H7 associated with marketing of unpasteurized milk in Kenya. Arimi SM; Koroti E; Kang'ethe EK; Omore AO; McDermott JJ Acta Trop; 2005 Oct; 96(1):1-8. PubMed ID: 16061190 [TBL] [Abstract][Full Text] [Related]
35. [Genetic changes in the composition of Brucella variant with persistently attenuated virulence]. Dubrovskaia II Vopr Med Khim; 1967; 13(2):168-75. PubMed ID: 4970399 [No Abstract] [Full Text] [Related]
36. Brucella abortus MFP: a trimeric coiled-coil protein with membrane fusogenic activity. Carrica Mdel C; Craig PO; Alonso Sdel V; Goldbaum FA; Cravero SL Biochemistry; 2008 Aug; 47(31):8165-75. PubMed ID: 18616282 [TBL] [Abstract][Full Text] [Related]
37. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51. Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615 [TBL] [Abstract][Full Text] [Related]
38. Molecular typing for epidemiological evaluation of Brucella abortus and Brucella canis isolated in Korea. Kang SI; Her M; Heo EJ; Nam HM; Jung SC; Cho D J Microbiol Methods; 2009 Aug; 78(2):144-9. PubMed ID: 19463862 [TBL] [Abstract][Full Text] [Related]
39. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle. Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273 [TBL] [Abstract][Full Text] [Related]
40. Development of a new PCR assay to identify Brucella abortus biovars 5, 6 and 9 and the new subgroup 3b of biovar 3. Ocampo-Sosa AA; Agüero-Balbín J; García-Lobo JM Vet Microbiol; 2005 Sep; 110(1-2):41-51. PubMed ID: 16029934 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]